After receiving his medical degree from the University of Leeds, Dr. Ghani trained in urology in Edinburgh and London. He also has a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of his sub-specialist training in endourology and stone disease at Guys Hospital, London, he undertook a minimally invasive urologic surgery fellowship at Henry Ford Hospital, Detroit. He joined the University of Michigan faculty in 2013, and oversees the Endourology program at the Ann Arbor VA. Dr. Ghani has authored over 100 peer-reviewed publications and is the editor of Endourology: A Practical Handbook. He is the Course Director of the “Developments in Ureteroscopic Stone Treatment (DUST)” course, which focuses on the Dusting technique for laser stone surgery. Dr. Ghani is also the Co-Director of the Michigan Urological Surgery Improvement Collaborative, statewide consortium of over 40 urology practices focused at improving urological care in the state of Michigan.

William W. Roberts, MD is Professor of Urology and Biomedical Engineering at the University of Michigan. He earned a B.S. in Physics from the Massachusetts Institute of Technology in 1992, an M.D. from the Johns Hopkins University School of Medicine in 1997, and completed his urology training at the Brady Urological Institute at Johns Hopkins. He joined the faculty of the University of Michigan in 2004 and is Director of the Division of Endourology. His clinical practice is focused on minimally invasive surgery, endourology, and urinary stone disease.

Dr. Roberts is part of the multidisciplinary scientific team at the University of Michigan that developed histotripsy, a non-invasive, focused ultrasound technology that induces controlled cavitation to mechanically ablate targeted tissues within the body. He is the director of the Endourology Translational Research Laboratory which is focused on optimization and safety of laser lithotripsy.

Dr. Roberts has presented his work at international and national meetings and has authored over 115 peer-reviewed publications. His research contributions have been recognized in the form of multiple grants and awards from the National Institutes of Health, American Urological Association Foundation, Coulter Foundation, Engineering and Urology Society, and Industry partners. He was the 2014 recipient of the prestigious AUA Gold Cystoscope Award.

Dr. Ambani is a native mid-Michigander, having grown up in Jackson, MI. After receiving his undergraduate degree from Harvard University, he obtained his medical degree from the University of Pittsburgh School of Medicine. He subsequently completed his Urology residency at the University of Michigan, and then stayed on to complete a fellowship in Laparoscopy, Robotics, and Stone Surgery. He subsequently joined the Endourology division of the University of Michigan Health System Department of Urology. His clinical interests include minimally-invasive surgery of the kidney and ureter, including ureteropelvic junction (UPJ) obstruction and complex ureteral reconstruction using small incisions, kidney masses, and kidney stone surgery. He also serves as the Associate Residency Program Director. He serves as the head of the University of Michigan Ureteral Reconstruction Working Group, which aims to improve the care of patients who require ureteral reconstruction surgery through clinical collaboration and research. Based on this work, he has a shared appointment in the division of Neurourology and Pelvic Reconstruction within the Department of Urology.

Dr. Brian Eisner is the Co-Director of the Kidney Stone Program at the MGH. He specializes in kidney stone surgery, kidney stone prevention and related research.

Dr. Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones, and laparoscopic surgery. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease and surgical treatment of kidney stones.

Dr. Bodo Knudsen a urologist, with a major focus on the management of kidney stones. At The Ohio State University Wexner Medical Center, he performed more than 500 surgeries a year related to kidney stones. Research at the Comprehensive Kidney Stone Program ties directly to his clinical program. Dr. Knudsen explores new treatments for kidney stones including medications and surgical techniques. He also studies the use of lasers in the treatment of stones. Dr. Knudsen’s goal is to personalize the health care delivered to each patient. He works with his patients to develop individualized treatment plans. Effective treatment of stones can provide relief of an acutely painful episode and also reduce future stone recurrences. Such treatment can significantly improve a patient’s quality of life.

Dr. Amy Krambeck is the Michael O. Koch Professor of Urology at Indiana University School of Medicine in Indianapolis, Indiana. Her Urology residency was completed at the Mayo Clinic in Rochester, Minnesota in 2008. Subsequently, from 2008 to 2009 she participated in an Endourology fellowship at the Methodist Institute for Kidney Stone Research in Indianapolis, Indiana. From 2009 to 2016 she worked as an Endourologist in the Mayo Clinic Department of Urology, then joined the staff at Indiana University in July of 2016. Dr. Krambeck specializes in the surgical and medical treatment of stone disease and benign prostatic hyperplasia. Her research interests include the pathogenesis of stone disease and the treatment of urolithiasis during pregnancy.

Dr. Nicole Miller currently holds the position of Associate Professor of Urology at Vanderbilt University School of Medicine in Nashville, TN. She joined the department in 2007. She completed her M.D. degree at the University of Pittsburgh School of Medicine in 2000, and received her urology residency training at the University of Virginia. Dr. Miller went on to complete a 2 year fellowship in Endourology and Minimally Invasive Surgery at the Indiana University School of Medicine under the mentorship of Dr. James E. Lingeman. She specializes in the medical and surgical treatment of kidney stone disease as well as laser surgery for BPH. Dr. Miller’s research interests include investigation of Randall’s plaque in the pathophysiology of nephrolithiasis, new laser technologies for kidney stone and BPH treatment, novel platforms for BPH surgery and investigation of pathophysiologic pathways for refractory BPH/LUTS. She has been the major contributor of transition zone prostate tissues from men undergoing surgery for refractory BPH/LUTS as part of Vanderbilt University’s Biorepository in the Center for Benign Urologic Diseases (CBUD) and has co-authored work on this developing resource. She has served as course faculty member and moderator both nationally and internationally for the American Urological Association and Endourological Society in the area of surgical treatment of BPH and nephrolithiasis. Dr. Miller is an Editorial Board Member for the Journal of Urology, Journal of Endourology and Co-director of the Minimally Invasive Surgery and Endourology Fellowship at Vanderbilt University Medical Center. She also served as a member of the AUA guidelines panel for the Surgical Management of Nephrolithiasis and AUA Leadership Class of 2017.

Dr. Ojas Shah is the George F. Cahill Professor of Urology at Columbia University College of Physicians and Surgeons. He also serves as the Director of the Division of Endourology and Stone Disease at Columbia University Medical Center. He is a graduate of the Honors Program in Medical Education at Northwestern University School of Medicine. He completed his general surgical and urologic training at New York University Medical Center. He spent an additional year at Wake Forest University Health Sciences Center as a fellow in endourology, laparoscopy and metabolic stone disease.

His clinical and research interests include surgical and metabolic treatments of kidney stone disease, minimally invasive urologic surgery, upper urinary tract urothelial carcinoma (transitional cell carcinoma), ureteral strictures, ureteropelvic junction (UPJ) obstruction, ureteral/renal reconstructive surgery, and BPH (benign prostate hyperplasia). He serves as the principal investigator in many clinical research trials regarding the surgical or medical management of stone disease. Dr. Shah serves as the Director of the Endourology Fellowship at Columbia University Medical Center. He additionally has a strong focus on medical student and resident education, and served as the urology residency program director at NYU School of Medicine prior to joining Columbia.

Dr. Shah recently served as a member of the American Urological Association’s Surgical Management of Stones Guidelines Committee. He is also a member of the American Board of Urology’s Examination Committee. He is an active member of the Endourological Society, EDGE (Endourology Disease Group for Excellence) Research Consortium, and ROCK (Research on Calculous Kinetics) Society. Dr. Shah was recently an Assistant Editor for the Journal of Urology, the most highly cited and amongst the most respected international journals in the field. He is also co-editor of the 5th Edition of Taneja’s Complications of Urologic Surgery which was released in 2018.